174 related articles for article (PubMed ID: 509177)
1. Haemostatic variables associated with diabetes and its complications.
Fuller JH; Keen H; Jarrett RJ; Omer T; Meade TW; Chakrabarti R; North WR; Stirling Y
Br Med J; 1979 Oct; 2(6196):964-6. PubMed ID: 509177
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic function tests associated with diabetic microangiopathy.
Fuller JH
Horm Metab Res Suppl; 1981; 11():59-62. PubMed ID: 6947950
[TBL] [Abstract][Full Text] [Related]
3. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus.
Sharma SC
J Clin Pathol; 1981 May; 34(5):501-3. PubMed ID: 7053039
[TBL] [Abstract][Full Text] [Related]
4. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
Chmielewski J
Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
[No Abstract] [Full Text] [Related]
5. Platelet and coagulation factors in proliferative diabetic retinopathy.
Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
[TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
7. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
[TBL] [Abstract][Full Text] [Related]
8. Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.
Mayne EE; Bridges JM; Weaver JA
Diabetologia; 1970 Aug; 6(4):436-40. PubMed ID: 5452393
[No Abstract] [Full Text] [Related]
9. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
[TBL] [Abstract][Full Text] [Related]
10. Coagulation profile in diabetes and its association with diabetic microvascular complications.
Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
[TBL] [Abstract][Full Text] [Related]
11. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
Fuller JH
Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
[No Abstract] [Full Text] [Related]
12. Antithrombin III deficiency in diabetes mellitus: influence on vascular degenerative complications.
Monnier L; Follea G; Mirouze J
Horm Metab Res; 1978 Nov; 10(6):470-3. PubMed ID: 744566
[TBL] [Abstract][Full Text] [Related]
13. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
14. Correlation of platelet aggregation, plasma factor activity, and megathrombocytes in diabetic subjects with an without vascular disease.
Colwell JA; Sagel J; Crook L; Chambers A; Laimins M
Metabolism; 1977 Mar; 26(3):279-85. PubMed ID: 319323
[TBL] [Abstract][Full Text] [Related]
15. [Letter: platelet aggregation and assay of Willebrand factor during diabetes mellitus].
Bensoussan D; Passa P; Canivet J; Lévy-Toledano S; Caen J
Nouv Presse Med; 1975 Jan; 4(3):195. PubMed ID: 1129082
[No Abstract] [Full Text] [Related]
16. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy.
Elder GE; Mayne EE; Daly JG; Kennedy AL; Hadden DR; Montgomery DA; Weaver JA
Haemostasis; 1980; 9(5):288-96. PubMed ID: 6157610
[TBL] [Abstract][Full Text] [Related]
17. Disturbances of haemostasis in diabetes mellitus.
Fattah MA; Shaheen MH; Mahfouz MH
Dis Markers; 2003-2004; 19(6):251-8. PubMed ID: 15258325
[TBL] [Abstract][Full Text] [Related]
18. Blood coagulation and fibrinolysis in obese NIDDM patients.
Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.
Jones SL; Close CF; Mattock MB; Jarrett RJ; Keen H; Viberti GC
BMJ; 1989 Feb; 298(6672):487-90. PubMed ID: 2495077
[TBL] [Abstract][Full Text] [Related]
20. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
Petersen KR; Skouby SO; Jespersen J
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
